Fundraising FoxJeffrey M. Liebmann
InvestorVice-Chair & Director of the Glaucoma Division, Department of Ophthalmology, Columbia University Medical Center at InFocus Capital Partners, LLC
Find your path to Jeffrey
17 people in our graph can introduce you to Jeffrey.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Rob Rothman to introduce you to Jeffrey
You →Rob · together at InFocus Capital Partners, LLC →Jeffrey
Ask Jamie Chen to introduce you to Jeffrey
You →Jamie · 11 people · together at InFocus Capital Partners, LLC →Jeffrey
Sign up to find every way you can get introduced to Jeffrey
- Your email: the people you already email who know Jeffrey
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jeffrey
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Advisory board member and Vice-Chair and Director of the Glaucoma Division at Columbia University Medical Center.
Colleagues at InFocus Capital Partners, LLC
Aron Shapiro
Senior Vice President, Asset Development & Partnering, Ora, Inc. at InFocus Capital Partners, LLC
Charles C. Wykoff
Director of Research, Retina Consultants of Houston at InFocus Capital Partners, LLC
David L. Katz
Medical Advisor, PL Developments at InFocus Capital Partners, LLC
Donald Fishbein
President, Evolve Therapeutics at InFocus Capital Partners, LLC
George Marinopoulos
General Partner at InFocus
Jeffrey Smith
CEO & Chief Investment Officer, Starboard Value LP at InFocus Capital Partners, LLC
Jodi Luchs
Chief Science Advisor at InFocus Capital Partners, LLC
Matt Chapin
Senior Vice President, Asset Development & Partnering, Ora, Inc. at InFocus Capital Partners, LLC
Frequently asked questions
- Who is Jeffrey M. Liebmann?
- Advisory board member and Vice-Chair and Director of the Glaucoma Division at Columbia University Medical Center.
- Where does Jeffrey M. Liebmann work?
- Jeffrey M. Liebmann is Vice-Chair & Director of the Glaucoma Division, Department of Ophthalmology, Columbia University Medical Center at InFocus Capital Partners, LLC.